Company intelligence / Profile preview

Upheal

Prague, Czech Republicupheal.io ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Upheal has developed an AI-driven SaaS platform that automates clinical note-taking, transcribes therapy sessions in multiple languages, analyzes session data (e.g., speech cadence, talking ratio), and provides actionable insights to therapists. The product aims to reduce administrative burden and clinician burnout while improving the quality of care. As of early 2024–2025, the company processes over 25K therapy/psychiatry sessions monthly. No clinical drug results are relevant as this is a digital tool.

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapyDevice (AI-powered software platform for mental health professionals)
Industry: Digital Health Medical Devices

Partnerships

Partnerships with healthcare providers/clinics using the SaaS solution; no major pharma or biotech partnerships disclosed

Beyond the preview

Go deeper on Upheal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Upheal.

Explore the full profile